| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Supplements |
1 From the Department of Paediatrics, University of British Columbia, Vancouver, Canada.
Animal studies have been of pivotal importance in advancing knowledge of the metabolism and roles of n–6 and n–3 fatty acids and the effects of specific dietary intakes on membrane composition and related functions. Advantages of animal studies include the rigid control of fatty acid and other nutrient intakes and the degree, timing, and duration of deficiency or excess, the absence of confounding environmental and clinical variables, and the tissue analysis and testing procedures that cannot be performed in human studies. However, differences among species in nutrient requirements and metabolism and the severity and duration of the dietary treatment must be considered before extrapolating results to humans. Studies in rodents and nonhuman primates fed diets severely deficient in 
-linolenic acid (18:3n–3) showed altered visual function and behavioral problems, and played a fundamental role by identifying neural systems that may be sensitive to dietary n–3 fatty acid intakes; this information has assisted researchers in planning clinical studies. However, whereas animal studies have focused mainly on 18:3n–3 deficiency, there is considerable clinical interest in docosahexaenoic acid (22:6n–3) and arachidonic acid (20:4n–6) supplementation. Information from animal studies suggests that brain and retinal concentrations of 22:6n–3 plateau with 18:3n–3 intakes of 
0.7% of energy, but this requirement is influenced by dietary 18:2n–6 intake. Blood and tissue concentrations of 22:6n–3 increase as 22:6n–3 intake increases, with adverse effects on growth and function at high intakes. Animal studies can provide important information on the mechanisms of both beneficial and adverse effects and the pathways of brain 22:6n–3 uptake.
Key Words: Essential fatty acids • n–6 fatty acids • n–3 fatty acids • arachidonic acid • docosahexaenoic acid • -linolenic acid • animal studies • animal models • infant development • neurologic development • retina • brain • fatty acid requirements • visual function
This article has been cited by other articles:
|
|
 |
|
  J. C McCann and B. N Ames Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals Am. J. Clinical Nutrition, August 1, 2005; 82(2): 281 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Mollard, H. R. Kovacs, S. C. Fitzpatrick-Wong, and H. A. Weiler Low Levels of Dietary Arachidonic and Docosahexaenoic Acids Improve Bone Mass in Neonatal Piglets, but Higher Levels Provide No Benefit J. Nutr., March 1, 2005; 135(3): 505 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Korotkova, B. Gabrielsson, M. Lonn, L.-A. Hanson, and B. Strandvik Leptin levels in rat offspring are modified by the ratio of linoleic to {alpha}-linolenic acid in the maternal diet J. Lipid Res., October 1, 2002; 43(10): 1743 - 1749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Mathews, W. T. Oliver, O. T. Phillips, J. Odle, D. A. Diersen-Schade, and R. J. Harrell Comparison of Triglycerides and Phospholipids as Supplemental Sources of Dietary Long-Chain Polyunsaturated Fatty Acids in Piglets J. Nutr., October 1, 2002; 132(10): 3081 - 3089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lapillonne, J. C. DeMar, V. Nannegari, and W. C. Heird The Fatty Acid Profile of Buccal Cheek Cell Phospholipids Is a Noninvasive Marker of Long-Chain Polyunsaturated Fatty Acid Status in Piglets J. Nutr., August 1, 2002; 132(8): 2319 - 2323. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
